Connect with us

NewsMakers

OMRON spearheads campaign to encourage Filipinos to monitor their blood pressure

To get rid of the steady growth of hypertension cases in the country, OMRON Healthcare Philippines, together with the Philippine Society of Hypertension (PSH), the Philippines Heart Association (PHA), and other health partners, spearheaded a campaign that encourages Filipinos to monitor their blood pressure (BP) at home to promote hypertension prevention, detection and control.

Published

on

High blood pressure is the leading cause of death in the Philippines. It is estimated that around 120,000 Filipinos are dying annually, directly or indirectly, due to hypertension-related complications such as stroke, heart attack and other cardiovascular diseases.

Likewise, the number of hypertensive Filipinos continues to increase as many of them are unaware that they have high blood pressure. There are no symptoms and some people only find out they have hypertension after they suffer a stroke or heart attack.

To get rid of the steady growth of hypertension cases in the country, OMRON Healthcare Philippines, together with the Philippine Society of Hypertension (PSH), the Philippines Heart Association (PHA), and other health partners, spearheaded a campaign that encourages Filipinos to monitor their blood pressure (BP) at home to promote hypertension prevention, detection and control.

An effective way to detect hypertension is through daily self-monitoring of BP at home. This is recommended to obtain reliable BP readings as monitoring is taken within the comfort of one’s home, helping patients feel more relaxed as they are surrounded by familiar environment. Home blood pressure levels considered normal are 130mmHg systolic BP and 80mmHg diastolic BP.  

Home BP monitoring can easily be adopted and practiced by anyone, whether living in urban or rural areas and belonging to any age groups. Performing regular BP monitoring is actually a cost-effective solution in the long-run compared with frequent visits to the doctor or hospital.  

Monitoring BP at home is encouraged to have a better understanding of a patient’s BP pattern, providing a chance of achieving BP control and reduce occurrence of hypertension-related complications.

The International Society of Hypertension (ISH), meanwhile, stresses the importance of regular screening to prevent complications caused by hypertension. To further this cause, ISH launched the May Measurement Month (MMM) initiative.

An annual global screening campaign, the MMM aims to raise awareness about risks and issues brought about by hypertension. Locally, the MMM is in line with Presidential Proclamation 1761 which was enacted on May 1, 2009 by then President Gloria Macapagal-Arroyo and declared the month of May of each year as Hypertension Awareness Month.

In the Philippines, the PSH leads the rollout of the campaign. The Philippines ranked first in terms of total screened individuals when the MMM was launched in May 2017, having a total 272,000 individuals screened or 22% of the global pooled data of 1.2-million for the same year.

“We aim to increase BP awareness to 80%, treatment rate to 60% and a control rate of 30% by 2022. At such rates, we are optimistic that we can reduce BP-related deaths by 25% and save about 30,000 Filipinos yearly. Through campaigns such as the May Measurement Month, we can further raise awareness about the importance of BP screening and other methods such as home BP monitoring, which are vital to averting hypertension complications,” notes Dr. Leilani B. Mercado-Asis, president of PSH.

This year, the nationwide BP screening and counseling campaign will be carried out by 20 government and non-government agencies. Dr. Alejandro F. Diaz, country lead of MMM 2019, is enthusiastic on screening 300,000 Filipinos with OMRON Healthcare Philippines as its official equipment partner. The OMRON digital BP monitoring devices are the only ones in the country to be clinically validated by PSH for accuracy and precision. Since MMM’s launch in 2017, OMRON has donated a total of 4,500 digital BP monitoring devices which measured the BP of over 400,000 Filipinos. For 2019, the company is donating 1,000 state-of-the-art digital BP monitoring devices.   

REYNALDO “Rey” R. VICENTE’s career experience involves mostly research in publishing companies. He previously held the position of Research and Events Director of Media G8way Corp., publisher of Computerworld Philippines (CWP), PC World Philippines, and IT Resource. He also handled events organized for CWP. Prior to this, he was a Research Head of a business publication. Now as co-publisher of Zest Magazine, Rey also serves as Managing Editor. Rey finished his bachelor’s degree majoring in Economics at the University of Santo Tomas.

NewsMakers

Pinay pioneers in biomedical and marine research win TOWNS 2022 Award

Two of the 11 winners of The Outstanding Women in the Nation’s Service (TOWNS) 2022 are both experts in life sciences from the UPD-CS.

Published

on

From the front lines of the COVID-19 pandemic to the forefront of ocean research, Filipina scientists from the University of the Philippines – Diliman College of Science (UPD-CS) are leading the country and the world in life sciences.

Two of the 11 winners of The Outstanding Women in the Nation’s Service (TOWNS) 2022 are both experts in life sciences from the UPD-CS. As Director of the National Institute of Molecular Biology and Biotechnology (NIMBB), Dr. Pia D. Bagamasbad has been a key player in the country’s pandemic response, while the Marine Science Institute’s (MSI’s) Dr. Aletta T. Yñiguez has continually been helping to improve the lives of fisherfolk and uplift the country’s fisheries sector through her work in marine ecology.

Spearheading Philippine COVID-19 response

With her years of extensive experience in using RT-PCR for various biomedical applications and assays, Dr. Bagamasbad quickly rose to prominence during the COVID-19 pandemic. Early on, she was able to train over a hundred medical technologists from dozens of testing laboratories and hospitals across the country in the use of RT-PCR testing. She is also deeply involved in research towards better understanding the molecular basis of hormone action and hormone-dependent cancers. As a researcher, she continually advocates government support for STEM practitioners, especially women scientists.

“My vision is for our country to get to a point where we have eliminated most, if not all, barriers to scientific progress, and prioritized the development of STEM professionals to give them enough motivation to stay,” Dr. Bagamasbad says.

ARAICoBeH, HABHub help empower fisherfolk

Meanwhile, Dr. Yñiguez is a well-known advocate of sustainable fishing practices and a staunch defender of marine ecology and biodiversity. Her marine research is focused on developing technologies and practices that can help oversee and protect coastal ecosystems, including an early-warning system for harmful algal blooms called HABHub. She and her team also developed a coastal monitoring system, officially called “A Rapid Assessment Instrument for Coastal Benthic Habitats”—but affectionately referred to by its tongue-in-cheek acronym, ARAICoBeH—that provides a low-cost way to take underwater photos of endangered areas such as coral reefs. Ultimately, Dr. Yñiguez is working towards forging close partnerships between coastal communities and public and private entities so that the science can be mainstreamed.

“It’s understandable that we want to have more and better production for a growing population and for economic growth, but the science and technologies to ensure sustainability and thus the health of the ecosystems for marine resources should also go hand-in-hand with these,” Dr. Yñiguez explains.

Inspiring future Filipina scientists

As professors at the UP Diliman College of Science, Drs. Bagamasbad and Yñiguez both continually inspire young students to become the country’s next generation of scientists. Their TOWNS win is a testament to the country and to the world of what Filipinas can aspire to and achieve. 

Since 1974, the TOWNS Awards have been bestowed on outstanding Filipino women between the ages 21 to 50 years old who have contributed invaluably to the country’s economic, social, and cultural development, as well as to national security and unity. The Awards are given every three years by the TOWNS Foundation, a non-profit organization whose members are committed to using their experience, skills, and resources to improve quality of life and to serve as catalysts for national development.

Continue Reading

NewsMakers

Eating late increases hunger, decreases calories burned, and changes fat tissue

Eating later had profound effects on hunger and appetite-regulating hormones leptin and ghrelin, which influence our drive to eat. Specifically, levels of the hormone leptin, which signals satiety, were decreased across the 24 hours in the late eating condition compared to the early eating conditions.

Published

on

Obesity afflicts approximately 42 percent of the adult population and contributes to the onset of chronic diseases, including diabetes, cancer, and other conditions. While popular healthy diet mantras advise against midnight snacking, few studies have comprehensively investigated the simultaneous effects of late eating on the three main players in body weight regulation and thus obesity risk: regulation of calorie intake, the number of calories you burn, and molecular changes in fat tissue. A new study by investigators from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, found that when we eat significantly impacts our energy expenditure, appetite, and molecular pathways in adipose tissue. Their results are published in Cell Metabolism.

“We wanted to test the mechanisms that may explain why late eating increases obesity risk,” explained senior author Frank A. J. L. Scheer, PhD, Director of the Medical Chronobiology Program in the Brigham’s Division of Sleep and Circadian Disorders. “Previous research by us and others had shown that late eating is associated with increased obesity risk, increased body fat, and impaired weight loss success. We wanted to understand why.”

“In this study, we asked, ‘Does the time that we eat matter when everything else is kept consistent?’” said first author Nina Vujović, PhD, a researcher in the Medical Chronobiology Program in the Brigham’s Division of Sleep and Circadian Disorders. “And we found that eating four hours later makes a significant difference for our hunger levels, the way we burn calories after we eat, and the way we store fat.”

Vujović, Scheer and their team studied 16 patients with a body mass index (BMI) in the overweight or obese range. Each participant completed two laboratory protocols: one with a strictly scheduled early meal schedule, and the other with the exact same meals, each scheduled about four hours later in the day. In the last two to three weeks before starting each of the in-laboratory protocols, participants maintained fixed sleep and wake schedules, and in the final three days before entering the laboratory, they strictly followed identical diets and meal schedules at home.

In the lab, participants regularly documented their hunger and appetite, provided frequent small blood samples throughout the day, and had their body temperature and energy expenditure measured. To measure how eating time affected molecular pathways involved in adipogenesis, or how the body stores fat, investigators collected biopsies of adipose tissue from a subset of participants during laboratory testing in both the early and late eating protocols, to enable comparison of gene expression patterns/levels between these two eating conditions.

Results revealed that eating later had profound effects on hunger and appetite-regulating hormones leptin and ghrelin, which influence our drive to eat. Specifically, levels of the hormone leptin, which signals satiety, were decreased across the 24 hours in the late eating condition compared to the early eating conditions. When participants ate later, they also burned calories at a slower rate and exhibited adipose tissue gene expression towards increased adipogenesis and decreased lipolysis, which promote fat growth. Notably, these findings convey converging physiological and molecular mechanisms underlying the correlation between late eating and increased obesity risk.

Vujović explains that these findings are not only consistent with a large body of research suggesting that eating later may increase one’s likelihood of developing obesity, but they shed new light on how this might occur. By using a randomized crossover study, and tightly controlling for behavioral and environmental factors such as physical activity, posture, sleep, and light exposure, investigators were able to detect changes the different control systems involved in energy balance, a marker of how our bodies use the food we consume.

In future studies, Scheer’s team aims to recruit more women to increase the generalizability of their findings to a broader population. While this study cohort included only five female participants, the study was set up to control for menstrual phase, reducing confounding but making recruiting women more difficult. Going forward, Scheer and Vujović are also interested in better understanding the effects of the relationship between meal time and bedtime on energy balance.

“This study shows the impact of late versus early eating. Here, we isolated these effects by controlling for confounding variables like caloric intake, physical activity, sleep, and light exposure, but in real life, many of these factors may themselves be influenced by meal timing,” said Scheer. “In larger scale studies, where tight control of all these factors is not feasible, we must at least consider how other behavioral and environmental variables alter these biological pathways underlying obesity risk. ”

Continue Reading

NewsMakers

DKSH, LEO Pharma partner to deliver products, solutions to people with skin conditions, thrombosis

DKSH Business Unit Healthcare, a leading partner for healthcare companies seeking to grow their business in Asia and beyond, has partnered with LEO Pharma to bring high-quality therapeutic products for dermatology and thrombosis to patients across Asia.

Published

on

DKSH Business Unit Healthcare, a leading partner for healthcare companies seeking to grow their business in Asia and beyond, has partnered with LEO Pharma to bring high-quality therapeutic products for dermatology and thrombosis to patients across Asia.

Partnering in Hong Kong, Malaysia, Singapore, Taiwan, Thailand, Vietnam, and the Philippines, the two companies seek to solidify brand presence, grow market share, and ultimately improve patient health outcomes in the region. Skin diseases can cause serious physical and social discomfort for millions of patients around the world whereas thrombosis can affect anyone regardless of their age, race, gender, and ethnicity.

DKSH will support LEO Pharma by building dedicated sales and marketing teams on the ground in Asia and managing logistics and product distribution in these markets. The firm’s experienced teams and broad distribution network will ensure LEO Pharma products reach modern trade, traditional trade, hospitals, clinics, and other medical channels, as well as patients in need across the region.

LEO Pharma is a global company dedicated to advancing the standard of care for the benefit of people with skin conditions, their families and society. With decades of research and development to advance the science of dermatology, LEO Pharma now offers a wide range of innovative treatments and therapies for all skin disease severities as well as thrombosis.

Khalid Aouidat, Vice President, responsible for commercial activities in Southeast Asia at LEO Pharma commented: “At LEO Pharma, we are dedicated to changing the standards of care for people with skin diseases by bringing new innovative treatments forward and making them easily accessible. Supporting this ambition, we are delighted to be partnering with DKSH. Their experience and strong regional footprint in Asia, as well as their marketing and sales expertise will help to further strengthen LEO Pharma’s brand and its continued growth.”

Bijay Singh, Head of Business Unit Healthcare at DKSH, said: “We are committed to enriching people’s lives and improving healthcare for all. The partnership with LEO Pharma strengthens our ambition to become the preferred partner for clients to help patients in Asia to have better access to high-quality and innovative products and solutions. While we drive their growth across the region, LEO Pharma can focus on researching and developing products and solutions for people with skin conditions.”

Continue Reading
Advertisement
Advertisement

Like Us On Facebook

Facebook Pagelike Widget

Most Popular

Copyright ©FRINGE PUBLISHING. All rights reserved.